MOUNTAIN VIEW, CA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)SYSTEMIC JIA FOUNDATION, founded in 2017, is a small nonprofit in the Medical Research sector that reported $159K in total revenue in fiscal year 2024. Revenue fell 54% from the prior year — a significant decline worth monitoring. Expenses of $143K left a modest 11% surplus.
1. TO SUPPORT RESEARCH RELATING TO TREATMENTS AND CURE OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS (SJIA); 2. PROMOTE INCREASED AWARENESS, KNOWLEDGE AND UNDERSTANDING OF SJIA BY MEDICAL PROFESSIONALS, THE GENERAL PUBLIC AND FAMILIES AFFECTED BY SJIA; 3. PROMOTE MUTUAL SUPPORT THROUGH BUILDING AND MAINTAINING AN EXTENSIVE WEB-BASED OR OTHER NETWORK OF INFORMATION AND RESOURCES FOR THE GENERAL PUBLIC AND FAMILIES.
SYSTEMIC JIA FOUNDATION PLANS SEVERAL TYPES OF FUNDRAISING: 1) DONATIONS FROM FAMILIES WITH SJIA: THE SYSTEMIC JIA FOUNDATION WILL REACH OUT TO FAMILIES WITH SJIA TO BOTH CONTRIBUTE AND RAISE FUNDS...
SYSTEMIC JIA FOUNDATION PLANS SEVERAL TYPES OF FUNDRAISING: 1) DONATIONS FROM FAMILIES WITH SJIA: THE SYSTEMIC JIA FOUNDATION WILL REACH OUT TO FAMILIES WITH SJIA TO BOTH CONTRIBUTE AND RAISE FUNDS FOR THE BENEFIT OF THE SYSTEMIC JIA FOUNDATION. THE SYSTEMIC JIA FOUNDATION WILL RAISE FUNDS ONLINE, USING FUNDRAISING SITES SUCH AS CROWDRISE, STRIPE, FACEBOOK OR FUNDRAISING FUNCTIONALITY ON OUR OWN WEBSITE.2) EVENT SPONSORSHIPS FROM PHARMA COMPANIES: FOR ANY EVENTS THE SYSTEMIC JIA FOUNDATION ORGANIZE, THE SYSTEMIC JIA FOUNDATION WILL REACH OUT TO PHARMA COMPANIES WHO ARE INTERESTED IN SJIA TO GIVE SPONSORSHIPS AT DIFFERENT LEVELS TO SUPPORT THE EVENT.3) GENERAL: THE SYSTEMIC JIA FOUNDATION WILL UNDERTAKE ADDITIONAL FUNDRAISING FROM A VARIETY OF SOURCES INCLUDING MAIL, EMAIL, PERSONAL AND PHONE SOLICITATIONS. THE ORGANIZATION WILL CREATE PROPOSALS AND OTHER MATERIALS THAT WILL BE NECESSARY TO SUBMIT IN ORDER FOR THE ORGANIZATION TO RECEIVE GRANTS AND DONATIONS.4) GRANTS FROM OTHER CHARITABLE ORGANIZATIONS. THE SYSTEMIC JIA FOUNDATION WILL RAISE ADDITIONAL FUNDS FROM OTHER CHARITABLE FOUNDATIONS.
CONFERENCES ATTENDED IN 2024PRES CONGRESS 2024 ATTENDED FROM SEPTEMBER 11, 2024 TO SEPTEMBER 14, 2024 AT GOTHENBURG SWEDEN.BRIEF DESCRIPTION: THE PRES (PEDIATRIC RHEUMATOLOGY EUROPEAN SOCIETY)...
CONFERENCES ATTENDED IN 2024PRES CONGRESS 2024 ATTENDED FROM SEPTEMBER 11, 2024 TO SEPTEMBER 14, 2024 AT GOTHENBURG SWEDEN.BRIEF DESCRIPTION: THE PRES (PEDIATRIC RHEUMATOLOGY EUROPEAN SOCIETY) CONFERENCE IS AN ANNUAL INTERNATIONAL EVENT FOCUSED ON ADVANCEMENTS IN PEDIATRIC RHEUMATOLOGY. IT'S A PLATFORM FOR HEALTHCARE PROFESSIONALS, RESEARCHERS, AND SCIENTISTS TO NETWORK, LEARN, AND SHARE THEIR KNOWLEDGE ON DIAGNOSING, TREATING, AND MANAGING RHEUMATIC DISEASES IN CHILDREN AND YOUNG PEOPLE.
NEXTGEN 2024 ORGANIZED FROM WEDNESDAY NOVEMBER 13, 2024 TO FRIDAY, NOVEMBER 15, 2024.DESCRIPTION: NEXTGEN CONFERENCE (AS WITH NEXTGEN IN PREVIOUS YEARS) AIMS TO ADVANCE THERAPIES FOR SJIA, STILL'S...
NEXTGEN 2024 ORGANIZED FROM WEDNESDAY NOVEMBER 13, 2024 TO FRIDAY, NOVEMBER 15, 2024.DESCRIPTION: NEXTGEN CONFERENCE (AS WITH NEXTGEN IN PREVIOUS YEARS) AIMS TO ADVANCE THERAPIES FOR SJIA, STILL'S DISEASE AND MAS. THE SPECIFIC FOCUS IN 2024 IS ON CLINICAL TRIALS AND BONE MARROW TRANSPLANTATION AS AN OPTION FOR REFRACTORY DISEASE. THE FOUNDATION INVITES ALL STAKEHOLDERS TO THE TABLE SUCH AS SCIENTISTS, CLINICIANS, PATIENT AND CAREGIVER REPRESENTATIVES, THE FDA / EMA, AND PHARMACEUTICAL COMPANIES.TOPICS INCLUDE:A COMPREHENSIVE LOOK AT IL18 (MEASURING IT, ROLE IN DISEASE, IL18-DRIVEN CLINICAL TRIALS), THERAPEUTIC OPTIONS FOR REFRACTORY PATIENTS (JAK-INHIBITORS & BEYOND), UPCOMING CLINICAL TRIALS IN SJIA, STILL'S & MAS BONE MARROW TRANSPLANTATION FOR REFRACTORY PATIENTS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $159,459 | $348,552 | -0.5% |
| Expenses | $142,526 | $361,009 | -0.6% |
| Net Income | $16,933 | $-12,457 | -2.4% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| JONATHAN BOUTELLE | DIRECTOR | 5.00 |
Director
|
$0 | $0 | $0 |
| RASHMI SINHA | DIRECTOR | 30.00 |
Director
|
$0 | $0 | $0 |
| MATTHEW MIGHT | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $159,459 | $142,526 | $106,554 | $16,933 |
| 2023 | $348,552 | $361,009 | $89,621 | $-12,457 |
| 2022 | $192,569 | $360,306 | $102,078 | $-167,737 |
| 2021 | $61,501 | $244,574 | $269,815 | $-183,073 |
| 2020 | $679,692 | $270,892 | $452,923 | $408,800 |
| 2019 | $90,432 | $50,886 | $44,098 | $39,546 |
| 2018 | No data | $458 | $4,552 | No data |
Compare SYSTEMIC JIA FOUNDATION with other nonprofits in California and across the country.